U.S. Markets closed
  • S&P 500

    3,693.23
    -64.76 (-1.72%)
     
  • Dow 30

    29,590.41
    -486.27 (-1.62%)
     
  • Nasdaq

    10,867.93
    -198.88 (-1.80%)
     
  • Russell 2000

    1,679.59
    -42.72 (-2.48%)
     
  • Crude Oil

    79.43
    -4.06 (-4.86%)
     
  • Gold

    1,651.70
    -29.40 (-1.75%)
     
  • Silver

    18.83
    -0.78 (-3.99%)
     
  • EUR/USD

    0.9693
    -0.0145 (-1.4733%)
     
  • 10-Yr Bond

    3.6970
    -0.0110 (-0.30%)
     
  • Vix

    29.92
    +2.57 (+9.40%)
     
  • GBP/USD

    1.0857
    -0.0398 (-3.5360%)
     
  • USD/JPY

    143.3300
    +0.9950 (+0.6991%)
     
  • BTC-USD

    19,026.96
    -65.78 (-0.34%)
     
  • CMC Crypto 200

    434.61
    -9.92 (-2.23%)
     
  • FTSE 100

    7,018.60
    -140.92 (-1.97%)
     
  • Nikkei 225

    27,153.83
    -159.30 (-0.58%)
     

Lowell Farms Inc. Announces Unaudited Second Quarter 2022 Financial and Operational Results

·16 min read
Lowell Farms Inc.
Lowell Farms Inc.

SALINAS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born innovator in cannabis cultivation and maker of the legendary brand Lowell Smokes, announces unaudited revenue and operating results for the second quarter (ended June 30, 2022). All figures stated are in US Dollars.

Second Quarter Financial Highlights:

  • Revenue generated for the three-month period ended June 30, 2022 was $13.2 million; an increase of 6% sequentially and down 13% from Q2 2021, reflecting a 51% reduction in bulk flower pricing year over year.

  • Bulk flower revenue increased 94% sequentially while declining 37% from Q2 levels last year due to lower pricing.

  • CPG revenue declined 18% sequentially and 23% from the prior year, as the company held pricing stable and reorganized its CPG offering.

  • Lowell brand revenues remain strong representing 66% of CPG revenues compared to 60% in the prior year.

  • Lowell Farm Services (LFS) revenue increased $1.2 million from the first quarter due to spring harvests and third-party bulk flower revenue.

  • Gross margin as reported was 11.3% in the second quarter compared to 12.7% sequentially and 37.9% year over year, reflecting strong bulk pricing in the prior year.

  • Operating expenses were $4.5 million or 34% of sales for the quarter, compared to $4.0 million or 33% of sales in the first quarter and $6.2 million or 41% of sales in the first quarter last year, reflecting cost reductions realized in the current year.

  • The operating loss in the second quarter was $3.0 million compared to an operating loss of $2.5 million sequentially and an operating loss of $0.5 million year-over-year, reflecting significantly lower bulk pricing year over year.

  • Net loss for the first quarter was $4.6 million compared sequentially to a net loss of $4.1 million, which compares to net income of $0.7 million in the second quarter last year, which included an insurance claim receipt of $2.6 million and favorable bulk flower pricing.

  • Adjusted EBITDA in the first quarter was negative $1.1 million compared sequentially to adjusted EBITDA of negative $0.9 million and positive adjusted EBITDA of $0.7 million year over year. Adjusted EBITDA is a non-GAAP financial measure. See “Use of Non-GAAP Financial Information” below for further information and a detailed reconciliation to Net Loss, the closest comparable GAAP measure.

Revenue Summary ($’s in ‘000)


 

 

 

 

 

Q/Q

Q/Q

 

 

March 31, 2022

June 30, 2022

 

% Change

$ Change

 

CPG Revenues

$9,077

$7,444

 

-18

%

(1,633

)

 

Bulk Product

$1,758

$3,415

 

94

%

1,657

 

 

LFS/Third-Party Bulk

$851

$2,048

 

141

%

1,197

 

 

Out-of-State Licensing

$723

$274

 

-62

%

(449

)

 

Net revenue

$12,409

$13,181

 

6

%

772

 

“California cannabis is in the middle of a fight for survival. There are fewer chairs at the table than there are attendees,” said Chairman of the Board George Allen. We will prevail through innovation and branding, and not by lowering our prices. While the second quarter is a disappointment, we are well prepared for our upcoming 35’s launch in September. ”

Subsequent events to the first quarter ended March 31, 2022:

Operational Highlights and Ongoing Initiatives:
The Company’s focus remains on key initiatives to drive sustainable profitable growth as well as working closely with governing bodies to ensure effective changes in the cannabis industry taxation system that would make higher profitability possible.

  • Cultivation Quality and Efficiency:

    • The Company’s focus on refining its cultivation processes, genetics, and facilities continue to improve the yield, potencies, and increase margins quarter over quarter.

      • Lowell Farms saw its flower production at the greenhouse continue to increase, with flower totaling 12,053 lbs during the second quarter of 2022 in comparison to 8,356 lbs in the first quarter of 2022.

        • The Company harvested 42 times in the second quarter of 2022; in contrast to 41 harvests in the first quarter of 2022.

        • The average turn time for the flowering rooms has seen continued improvement and is now at 57 days in the second quarter of 2022 compared to 58 days in the first quarter of 2022.

        • The Company continues to evolve its licenses and completed construction and received the Monterey County Cannabis Business permit, a prerequisite to the California Annual License.

  • Lowell Farm Services:

    • Lowell Farm Services, a first-of-its-kind cannabis processing facility in Salinas Valley, continues to improve operational efficiencies with a stronger focus on new clients and scalability.

      • As expected, Lowell Farm Services revenue increased 141% sequentially to $2.0 million.

      • Licensing revenue declined 62% sequentially to $0.3 million, partially on account of timing of packaging orders.

      • The sequential increase in Lowell Farm Services reflects revenue from third-party seasonal harvests and third-party bulk flower sales and the decline in licensing revenue reflects lower packaging shipments to licensees in the quarter.

  • Portfolio Brands, Bulk Product and Out-of-State Licensing:

    • CPG revenue declined 18% sequentially to $7.4 million and declined 23% year over year while bulk flower revenue increased 94% sequentially to $3.4 million, while declining 37% year over year.

      • The decline in CPG revenue is due to holding pricing stable and current efforts to reorganize edible and concentrates product offerings.

      • The Company sold approximately 6,374 lbs of bulk flower, a 76.8% increase sequentially.

    • Lowell Herb Co. revenues remain strong and represent 66% of CPG revenues in the current quarter compared to 60% in the second quarter last year.

      • Lowell Herb Co. ranked 10th amongst the top 30 brands in California in terms of lowest change in wholesale cost per gram (-2.6% from Q1 to Q2) which confirms the brand loyalty to be able to hold prices steady in an uber-competitive market.

      • In Q2, portfolio brands Lowell Herb Co. and House Weed combined for the 2nd highest sales in the combined categories of Flower and All-Flower Prerolls per Headset.

    • Out-of-state Licensing

      • Collectively out-of-state revenues fell from $723k in the first quarter of 2022 to $274k in the second quarter.

        • The drop included a decline in royalties from $389k to $263k.

        • The decline in royalties is something the Company is addressing with its partner within those markets.

        • The markets continue to experience supply disruptions during the quarter which contributed to sales declines.

      • The Company anticipates launching Colorado and New Mexico late in the third quarter with Schwazze and the team is bullish about their prospects in those markets.

“To compete with the illicit market, we have to do it with quality and value,” said CEO Mark Ainsworth. “Our whole plan is built on three pillars: exceptionally good cannabis, a brand that people trust, and automation. We are closer than ever to having all three.”

Q2 Financial Results Earnings Conference Call Details:
The conference call with management at 5:30 p.m. EDT on Tuesday, August 9, can be accessed using the following dial-in information:

U.S. and Canadian Toll Free: 1-877-407-0789
International: 1-201-689-8562
Webcast: Lowell Farms Inc.
Conference ID: 10169777

Please dial-in at least 10 minutes before the call to register.

The conference call will be webcast live and archived on the investor relations section of the Lowell Farms website at https://ir.lowellfarms.com/.

ABOUT LOWELL FARMS INC.
Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF) (the “Company”) is a California-based cannabis company with advanced production capabilities supporting every step of the supply chain, including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. Lowell Farms grows artisan craft cannabis with a deep love and respect for the plant, and prides itself on using sustainable materials – from seed to sale – to produce an extensive portfolio of award-winning originals, including Lowell Herb Co, House Weed and MOON, for licensed retailers statewide.

Lowell Farms Inc. Media Contact
pr@lowellfarms.com

Lowell Farms Inc. Investor Relations Contact
Bill Mitoulas
416.479.9547
ir@lowellfarms.com

Lowell Farms Inc. Company Contact
Mark Ainsworth
ir@lowellfarms.com

Forward-Looking Information and Statements
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current conditions, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved.” The forward-looking information and forward-looking statements contained herein may include, but are not limited to, the anticipated growth of Lowell Farm Services and the ability of the Company to successfully achieve its business objectives and expectations for other economic, business, and/or competitive factors. There can be no assurance that such forward-looking information and statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such forward-looking information and statements. This forward-looking information and statements reflect the Company’s current beliefs and are based on information currently available to the Company and on assumptions the Company believes are reasonable.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; operating and development costs; competition; changes in legislation or regulations affecting the Company; the timing and availability of external financing on acceptable terms; the available funds of the Company and the anticipated use of such funds; favorable production levels and outputs; the stability of pricing of cannabis products; the level of demand for cannabis product; the availability of third-party service providers and other inputs for the Company’s operations; lack of qualified, skilled labor or loss of key individuals; and risks and delays resulting from the COVID-19 pandemic. A description of additional assumptions used to develop such forward-looking information and a description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company’s disclosure documents, such as the Company’s annual information form filed on the SEDAR website at www.sedar.com and the Company's Form 10 filed on the SEC website at www.sec.com. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement.

The forward-looking information contained in this news release represents the expectations of the Company as of the date of this news release and, accordingly, is subject to change after such date. However, the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Neither the Canadian Securities Exchange nor its Regulation Service Provider has reviewed, or accepts responsibility for the adequacy or accuracy of, the content of this news release.

Use of Non-GAAP Financial Information

EBITDA is net income (loss), excluding the effects of income taxes (recovery); net interest expense; depreciation and amortization; and adjusted EBITDA also includes noncash fair value adjustments on investments; unrealized foreign currency gains/losses; share-based compensation expense; and other transactional and special expenses, such as out-of-period insurance recoveries and acquisition costs and expenses related to the markup of acquired finished goods inventory, which are inconsistent in amount and frequency and are not what we consider as typical of our continuing operations. Management believes this measure provides useful information as it is a commonly used measure in the capital markets and as it is a close proxy for repeatable cash generated by operations. We use adjusted EBITDA internally to understand, manage, make operating decisions related to cash flow generated from operations and evaluate our business. In addition, we use adjusted EBITDA to help plan and forecast future periods.

This measure is not necessarily comparable to similarly titled measures used by other companies. A reconciliation of this measure to Net Loss is provided below.


Condensed Consolidated Balance Sheets

 

 

(unaudited)

 

 

(in thousands)

 

 

 

June 30,

December 31,

 

 

2022

 

 

2021

 

ASSETS

 

 

Current assets:

 

 

Cash and cash equivalents

$

2,205

 

$

7,887

 

Accounts Receivable - net of allowance for doubtful accounts of $1,139 at June 30, 2022 and December 31, 2021

 

6,040

 

 

8,222

 

Inventory

 

14,930

 

 

13,343

 

Prepaid expenses and other current assets

 

2,880

 

 

1,976

 

Total current assets

 

26,055

 

 

31,428

 

Property and equipment, net

 

62,526

 

 

64,779

 

Other intangibles, net

 

40,593

 

 

40,756

 

Other assets

 

309

 

 

416

 

 

 

 

Total assets

$

129,483

 

$

137,379

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

Current liabilities:

 

 

Accounts payable

$

3,329

 

$

3,102

 

Accrued payroll and benefits

 

831

 

 

650

 

Notes payable, current portion

 

301

 

 

221

 

Lease obligation, current portion

 

2,563

 

 

2,444

 

Other current liabilities

 

4,575

 

 

3,706

 

Total current liabilities

 

11,599

 

 

10,123

 

Notes payable

 

6

 

 

28

 

Lease obligation

 

32,737

 

 

34,052

 

Convertible debentures

 

14,400

 

 

14,012

 

Mortgage obligation

 

8,787

 

 

8,857

 

Total liabilities

 

67,529

 

 

67,072

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

Share capital

 

189,686

 

 

189,368

 

Accumulated deficit

 

(127,732

)

 

(119,061

)

Total stockholders' equity

 

61,954

 

 

70,307

 

 

 

 

Total liabilities and stockholders' equity

$

129,483

 

$

137,379

 

 

 

 



 

Condensed Consolidated Statements of Cash Flows

 

 

 

 

 

(unaudited)

 

 

 

 

 

(in thousands)

 

 

 

 

 

 

 

Six Months Ended

 

 

 

June 30,

 

June 30,

 

 

 

2022

 

2021

 

CASH FLOW FROM OPERATING ACTIVITIES

 

 

 

 

 

Net loss

 

$

(8,671

)

 

$

(5,988

)

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

Depreciation and amortization

 

 

3,433

 

 

 

1,858

 

 

Amortization of debt issuance costs

 

 

451

 

 

 

420

 

 

Share-based compensation expense

 

 

318

 

 

 

625

 

 

Provision for doubtful accounts

 

 

459

 

 

 

173

 

 

Loss on sale of assets

 

 

8

 

 

 

-

 

 

Termination of branding rights agreement

 

 

-

 

 

 

152

 

 

Unrealized loss (gain) on change in fair value of investments

 

 

107

 

 

 

(125

)

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

 

1,723

 

 

 

(1,526

)

 

Inventory

 

 

(1,587

)

 

 

(1,501

)

 

Prepaid expenses and other current assets

 

 

(904

)

 

 

(553

)

 

Accounts payable and accrued expenses

 

 

1,277

 

 

 

(4,320

)

 

Net cash used in operating activities

 

$

(3,386

)

 

$

(10,785

)

 

CASH FLOW FROM INVESTING ACTIVITIES

 

 

 

 

 

Proceeds from asset sales

 

$

5

 

 

$

1,979

 

 

Purchases of property and equipment

 

 

(1,030

)

 

 

(608

)

 

Acquisition of business assets, net

 

 

-

 

 

 

(6,642

)

 

Net cash used in investing activities

 

$

(1,025

)

 

$

(5,271

)

 

CASH FLOW FROM FINANCING ACTIVITIES

 

 

 

 

 

Principal payments on lease obligations

 

 

(1,196

)

 

 

(1,164

)

 

Payments on notes payable

 

 

(75

)

 

 

(128

)

 

Proceeds from exercise of warrants and options

 

 

-

 

 

 

710

 

 

Net cash used by financing activities

 

$

(1,271

)

 

$

(582

)

 

 

 

 

 

 

 

Change in cash and cash equivalents

 

 

(5,682

)

 

 

(16,638

)

 

Cash and cash equivalents—beginning of year

 

 

7,887

 

 

 

25,751

 

 

Cash, cash equivalents —end of period

 

$

2,205

 

 

$

9,113

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

Cash paid during the period for interest

 

$

2,655

 

 

$

605

 

 

Cash paid during the period for income taxes

 

$

60

 

 

$

187

 

 

 

 

 

 

 

 

OTHER NONCASH INVESTING AND FINANCING ACTIVITIES

 

 

 

 

 

Purchase of property and equipment not yet paid for

 

$

58

 

 

$

-

 

 

Issuance of subordinate voting shares in exchange for net assets acquired

 

$

-

 

 

$

43,259

 

 

Liabilities assumed and receivable forgiveness in exchange for net assets acquired

 

$

-

 

 

$

2,910

 

 

Debt and associated accrued interest converted to subordinate voting shares

 

$

-

 

 

$

478

 

 

 

 

 

 

 



 

Condensed Consolidated Statements of Income (Loss)
(unaudited)
(in thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

 

June 30,

 

June 30,

 

June 30,

 

June 30,

 

 

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

Net revenue

 

 

$

13,181

 

 

$

15,157

 

 

$

25,589

 

 

$

26,183

 

 

 

Cost of goods sold

 

 

 

11,687

 

 

 

9,413

 

 

 

22,522

 

 

 

21,915

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

 

1,494

 

 

 

5,744

 

 

 

3,067

 

 

 

4,268

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

 

2,649

 

 

 

3,817

 

 

 

4,813

 

 

 

6,285

 

 

 

Sales and marketing

 

 

 

1,747

 

 

 

2,233

 

 

 

3,508

 

 

 

3,667

 

 

 

Depreciation and amortization

 

 

 

123

 

 

 

167

 

 

 

231

 

 

 

491

 

 

 

Total operating expenses

 

 

 

4,519

 

 

 

6,217

 

 

 

8,552

 

 

 

10,443

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

 

(3,025

)

 

 

(473

)

 

 

(5,485

)

 

 

(6,175

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income/(expense)

 

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

(156

)

 

 

1,858

 

 

 

(295

)

 

 

1,416

 

 

 

Unrealized change in fair value of investment

 

 

 

(36

)

 

 

18

 

 

 

(107

)

 

 

124

 

 

 

Interest expense

 

 

 

(1,337

)

 

 

(598

)

 

 

(2,649

)

 

 

(1,215

)

 

 

Total other income (expense)

 

 

 

(1,529

)

 

 

1,278

 

 

 

(3,051

)

 

 

325

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before provision for income taxes

 

 

(4,554

)

 

 

805

 

 

 

(8,536

)

 

 

(5,850

)

 

 

Provision for income taxes

 

 

 

60

 

 

 

74

 

 

 

135

 

 

 

138

 

 

 

Net income (loss)

 

 

$

(4,614

)

 

$

731

 

 

$

(8,671

)

 

$

(5,988

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

$

(0.04

)

 

$

0.01

 

 

$

(0.08

)

 

$

(0.10

)

 

 

Diluted

 

 

$

(0.04

)

 

$

0.00

 

 

$

(0.08

)

 

$

(0.10

)

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 

112,026

 

 

 

71,021

 

 

 

111,981

 

 

 

61,956

 

 

 

Diluted

 

 

 

112,026

 

 

 

201,278

 

 

 

111,981

 

 

 

61,956

 

 

 

 

 

 

 

 

 

 

 

 

 

 



The table below reconciles Net Loss to Adjusted EBITDA for the periods indicated.

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30,

 

June 30,

 

June 30,

 

June 30,

 

(in thousands)

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

Net income (loss)

 

$

(4,614

)

 

$

731

 

 

$

(8,671

)

 

$

(5,988

)

 

Interest expense

 

 

1,339

 

 

 

598

 

 

 

2,649

 

 

 

1,215

 

 

Provision for income taxes

 

 

60

 

 

 

75

 

 

 

135

 

 

 

138

 

 

Depreciation and amortization in cost of goods sold

 

 

1,628

 

 

 

584

 

 

 

2,888

 

 

 

1,168

 

 

Depreciation and amortization in operating expenses

 

 

123

 

 

 

167

 

 

 

231

 

 

 

491

 

 

Depreciation and amortization in other income (expense)

 

 

171

 

 

 

195

 

 

 

314

 

 

 

195

 

 

EBITDA(1)

 

 

(1,293

)

 

 

2,350

 

 

 

(2,454

)

 

 

(2,781

)

 

Investment and currency (gains)/ losses

 

 

37

 

 

 

(19

)

 

 

107

 

 

 

(125

)

 

Share-based compensation

 

 

157

 

 

 

336

 

 

 

318

 

 

 

625

 

 

Net effect of cost of goods on mark-up of acquired finished goods inventory

 

 

-

 

 

 

497

 

 

 

-

 

 

 

662

 

 

Transaction and other special charges

 

 

-

 

 

 

(2,424

)

 

 

30

 

 

 

(2,424

)

 

Adjusted EBITDA(1)

 

$

(1,099

)

 

$

740

 

 

$

(1,999

)

 

$

(4,043

)

 

(1) Non-GAAP measure